New Perspectives on the Conservative Management of Osteoradionecrosis of the Mandible: a Literature Review

Over the last decades, several therapeutic options were considered in the treatment of the osteoradionecrosis (ORN) of the mandible, including supportive measures, ultrasound therapy, corticosteroids, hyperbaric oxygen, surgical resection with reconstruction, and, more recently, drugs capable of reversing the fibroatrophic process. Once established, the ORN does not spontaneously disappear and a standard treatment has not yet been defined. The clear clinical effectiveness of hyperbaric oxygen therapy (HBOT) varies according to the literature and there are some economic/logistic issues to be considered; the triplet tocopherol/pentoxifylline/clodronate demands greater evidence from randomized clinical trials and also resilience from the patient, given the long treatment duration and its possible side effects. Controversy around the ideal treatment of the initial stage ORN of the mandible persists. More rigorous randomized prospective trials are essential. The purpose of this article was to review the relevant literature on the physiopathology of ORN of the mandible and discuss the new perspectives of its conservative treatment. © 2016 Wiley Periodicals, Inc. Head Neck 38: 1708-1716, 2016.

Keywords

HSJ CIR MAXFAC HSJ CIR Humans Antioxidants / therapeutic use Bone Density Conservation Agents / therapeutic use Clodronic Acid / therapeutic use Conservative Treatment Drug Therapy, Combination Hyperbaric Oxygenation* Mandibular Diseases / therapy* Osteoradionecrosis / drug therapy Osteoradionecrosis / physiopathology Osteoradionecrosis / therapy* Pentoxifylline / therapeutic use Tocopherols / therapeutic use